Medicure medicure.com

Medicure (TSXV:MPH) (OTC:MCUJF) is a specialty pharmaceutical company focused on the development and commercialization of novel small molecule therapeutics. The primary focus of the Company and its subsidiaries is the marketing and distribution of AGGRASTAT (tirofiban HCl) for non-ST elevation acute coronary syndrome in the United States, where it is sold through the Company's U.S. subsidiary, Medicure Pharma.

Medicure (TSXV:MPH) (OTC:MCUJF) is a specialty pharmaceutical company focused on the development and commercialization of novel small molecule therapeutics. The primary focus of the Company and its subsidiaries is the marketing and distribution of AG...Show all

See All Exits Recent Exits

Phone: 204-487-7412

Fax:

2-1250 Waverley Street

Winnipeg, R3T 6C6
Manitoba, Canada

Medicure - Investments & Acquisitions

Show Real Data Medicure Investments
See all Recent Investments
Date Company Round Amount Co-investors
2017-07-12ApicoreCorporate Majority - III$24.5M
2016-11-18ApicoreCorporate Majority - II
2014-07-03ApicoreCorporate Minority$6.83M
See all 3 investments